Diploma (LON:DPLM) Shares Up 15.1% – Here’s Why

Diploma PLC (LON:DPLM) shares shot up 15.1% on Wednesday . The stock traded as high as GBX 5,025 ($67.30) and last traded at GBX 4,860 ($65.09). 975,747 shares were traded during trading, an increase of 115% from the average session volume of 453,933 shares. The stock had previously closed at GBX 4,222 ($56.54).

Diploma Stock Performance

The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The firm’s 50-day moving average is GBX 3,949.28 and its two-hundred day moving average is GBX 4,253.28. The stock has a market cap of £6.49 billion, a price-to-earnings ratio of 55.89, a P/E/G ratio of 2.82 and a beta of 0.75.

Diploma (LON:DPLM) last released its quarterly earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.07) earnings per share for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. As a group, sell-side analysts expect that Diploma PLC will post 163.7995512 earnings per share for the current year.

Insider Buying and Selling at Diploma

In other Diploma news, insider Ian El-Mokadem acquired 500 shares of the business’s stock in a transaction on Monday, March 24th. The stock was bought at an average price of GBX 3,948 ($52.87) per share, for a total transaction of £19,740 ($26,436.32). Also, insider David S. Lowden acquired 750 shares of the business’s stock in a transaction on Friday, March 21st. The stock was acquired at an average price of GBX 3,928 ($52.60) per share, with a total value of £29,460 ($39,453.60). 0.52% of the stock is owned by insiders.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.